Advertisement

Rocuronium Injection

[21 February 2017]

Products Affected - Description

Rocuronium Bromide solution for injection, Fresenius Kabi
10 mg/mL, 5 mL vial, 10 count (NDC 63323-0426-05)
10 mg/mL, 10 mL vial, 10 count (NDC 63323-0426-10)
 
Rocuronium Bromide solution for injection, Pfizer
10 mg/mL, 5 mL vial, 10 count (NDC 00409-9558-05)
10 mg/mL, 10 mL vial, 10 count (NDC 00409-9558-10)
 
Rocuronium Bromide solution for injection, Sagent
10 mg/mL, 5 mL vial, 10 count (NDC 25021-0662-05)
10 mg/mL, 10 mL vial, 10 count (NDC 25021-0662-10)
 
Rocuronium Bromide solution for injection, X-Gen
10 mg/mL, 5 mL vial, 10 count (NDC 39822-4200-02)

Reason for the Shortage

  • Fresenius Kabi has rocuronium on shortage due to delay of raw materials.
  • Pfizer has rocuronium on shortage due to manufacturing delays.
  • Sagent has rocuronium on shortage due to increased demand.
  • X-Gen has rocuronium on shortage due to increased demand.

Available Products

Rocuronium Bromide solution for injection, Mylan Institutional
10 mg/mL, 5 mL vial, 10 count (NDC 67457-0228-05)
10 mg/mL, 10 mL vial, 10 count (NDC 67457-0228-10)
 
Rocuronium Bromide solution for injection, Sandoz
10 mg/mL, 5 mL vial, 10 count (NDC 00781-3220-95)
10 mg/mL, 10 mL vial, 10 count (NDC 00781-3220-92)
 
Rocuronium Bromide solution for injection, X-Gen
10 mg/mL, 10 mL vial, 10 count (NDC 39822-4200-06)

Estimated Resupply Dates

  • Fresenius Kabi has rocuronium 10 mg/mL 5 mL and 10 mL vials on back order and the company estimates a release date of 2nd quarter 2017.
  • Pfizer has rocuronium 10 mg/mL 5 mL and 10 mL vials available in limited supply.
  • Sagent has rocuronium 10 mg/mL 5 mL and 10 mL vials on back order and the company estimates a release date of March 2017 for the 5 mL vials and February 2017 for the 10 mL vials.
  • X-Gen has rocuronium on 10 mg/mL 5 mL vials on back order and the company estimates a release date of mid-March 2017.

Related Shortages

Updated

February 21, 14 and 9, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing